BioXcellerator Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
2
BioXcellerator General Information
Description
Operator of stem cell therapy services intended to serve people with autoimmune and degenerative diseases. The company offers therapies and skincare creams that are used for various problems such as sports and orthopedic injuries, anti-aging and cosmetic treatments and life-threatening and debilitating diseases like Alzheimer's disease, diabetes and leukemia, enabling them to get advanced stem cell therapies at an affordable rate.
Contact Information
Website
www.bioxcellerator.com
Formerly Known As
Bioscience Americas, LLC
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
- 2122 East Highland Avenue
- Suite 265
- Phoenix, AZ 85016
- United States
+1 (888) 000-0000
BioXcellerator Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioXcellerator Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Eric Stoffers | Chief Executive Officer & Founder | ||
| Michael Alexander | Chief Marketing Officer |
BioXcellerator Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
BioXcellerator Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|